Nisa Investment Advisors’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-180
Closed -$15K 2405
2020
Q3
$15K Hold
180
﹤0.01% 2075
2020
Q2
$6K Sell
180
-1,240
-87% -$36.3K ﹤0.01% 2004
2020
Q1
$19K Buy
1,420
+330
+30% +$5.55K ﹤0.01% 1719
2019
Q4
$23K Hold
1,090
﹤0.01% 1674
2019
Q3
$14K Buy
1,090
+430
+65% +$6.32K ﹤0.01% 1708
2019
Q2
$9K Hold
660
﹤0.01% 1797
2019
Q1
$13K Hold
660
﹤0.01% 1698
2018
Q4
$9K Hold
660
﹤0.01% 1690
2018
Q3
$14K Buy
660
+160
+32% +$3.79K ﹤0.01% 1635
2018
Q2
$12K Hold
500
﹤0.01% 1694
2018
Q1
$7K Sell
500
-800
-62% -$13.1K ﹤0.01% 1755
2017
Q4
$21K Buy
1,300
+200
+18% +$2.36K ﹤0.01% 1544
2017
Q3
$15K Hold
1,100
﹤0.01% 1626
2017
Q2
$10K Sell
1,100
-400
-27% -$2.81K ﹤0.01% 1736
2017
Q1
$10K Buy
+1,500
New +$7.6K ﹤0.01% 1682

Nisa Investment Advisors's IMMU Position: Q4 2020 in Review

Nisa Investment Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 180 shares — an estimated $15K sold.

Nisa Investment Advisors first reported a position in IMMU in Q1 2017 and held it in 15 quarters. The position peaked at $23K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Nisa Investment Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Nisa Investment Advisors sold 180 Immunomedics Inc shares in Q4 2020, an estimated $15K.
  • Nisa Investment Advisors first reported a position in Immunomedics Inc in Q1 2017 and held it in 15 quarters.
  • Nisa Investment Advisors's Immunomedics Inc position peaked at $23K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.